Plain-English translation of NCT06377033 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing different ways to encourage patients and doctors to consider genetic testing when it might help guide medical care. The study sends text messages to patients or alerts to doctors—or both—to see which approach works best at helping people get genetic testing for conditions like ALS, Parkinson disease, heart problems, and other inherited disorders.
Many patients who could benefit from genetic testing never get it, because doctors and patients often stick with the usual approach even when a genetic test could change treatment decisions. This study wants to find simple, respectful ways to remind both patients and doctors about genetic testing as an option.
You likely qualify if…
You likely don't qualify if…
If you're in this study, you may receive a text message encouraging you to talk with your doctor about genetic testing, or your doctor may receive a computer alert suggesting genetic testing—or both. The study will follow you for up to 3 years, tracking whether you get genetic testing and how it affects your care. You won't need to come in for special visits; the study works through your regular medical care and your electronic health record.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States
Sponsor
University of Pennsylvania
Enrollment target
~1,000 participants
Started
June 2024
Primary completion
June 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Benita Weathers, MPH
University of Pennsylva
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.